A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety and Tolerability of 20 mg/kg Dose of Ro4905417 Administered Every 4 Weeks for 32 Weeks in Patients Undergoing Coronary Artery Bypass Surgery (CABG)

  • Ramaiah, Chandrashekhar (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/10/11 → 12/31/13